“Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype” (2016) Radiology and Oncology, 50(4). Available at: https://www.radioloncol.com/index.php/ro/article/view/2580 (Accessed: 4 November 2026).